Bone and Calcium

ea0044p42 | Bone and Calcium

The mechanistic role of fibroblast growth factor 21 in growth hormone resistance secondary to chronic childhood conditions

ea0044p43 | Bone and Calcium

The influence of gender on the bone health of adolescent patients with hormonal deficiencies

ea0044p44 | Bone and Calcium

The calcilytic SHP635 rectifies hypocalcaemia and reduced parathyroid hormone concentrations in a mouse model for autosomal dominant hypocalcaemia type 1 (ADH1)

ea0044p45 | Bone and Calcium

Immunomodulation by vitamin D is associated with regulation of microRNAs

ea0044p46 | Bone and Calcium

Ionised calcium from blood gas measurements, often overlooked

ea0044p47 | Bone and Calcium

Studies of an Autosomal Dominant Hypocalcemia type-1 (ADH1) associated calcium-sensing receptor (CaSR) mutation, Arg680Gly, provides insights into biased signalling

ea0044p48 | Bone and Calcium

Emergency management of hypercalcemia (an audit of SfE guidance in Oxford)

ea0044p49 | Bone and Calcium

The impact of primary hyperparathyroidism and its treatment on bone mineral density, bone mineral parameters, insulin resistance, body composition and quality of life – A prospective pilot study from India

ea0044p50 | Bone and Calcium

Impact of hepatitis B-related chronic liver disease and its therapy on bone health

ea0044p51 | Bone and Calcium

An audit of the management of patients with hypoparathyroidism

ea0044p52 | Bone and Calcium

Continuous synthetic PTH_1-34 replacement therapy in the treatment of autosomal dominant hypoparathyroidism type 1

ea0044p53 | Bone and Calcium

Importance of bone mineral density care in transitional endocrine service

ea0044p54 | Bone and Calcium

Surgical management of primary hyperparathyroidism in East Sussex Healthcare NHS Trust (retrospective audit of patients had parathyroidectomy over 2 years in East Sussex NHS Trust)

ea0044p55 | Bone and Calcium

Preoperative localisation for parathyroid surgery in primary hyperparathyroidism: a study to evaluate the clinical utility of different imaging modalities

ea0044p56 | Bone and Calcium

An audit of vertebral fracture assessment (VFA) selection criteria: Implications for the service and impact on clinical decision making

ea0044p57 | Bone and Calcium

Initial experience of a newly established intra-operative PTH service

ea0044p58 | Bone and Calcium

Procollagen N-terminal propeptide in children

ea0044p59 | Bone and Calcium

Primary hyperparathyroidism and concomitant vitamin D deficiency: Study of diagnosis and management outcomes

ea0044p60 | Bone and Calcium

Would a 10% fracture risk threshold for direct access to dual energy densitometry (DXA) exclude patients with low bone mineral density?

ea0044p61 | Bone and Calcium

Endocrine Abstracts

Society for Endocrinology BES 2016

Poster Presentations

The mechanistic role of fibroblast growth factor 21 in growth hormone resistance secondary to chronic childhood conditions

The influence of gender on the bone health of adolescent patients with hormonal deficiencies

The calcilytic SHP635 rectifies hypocalcaemia and reduced parathyroid hormone concentrations in a mouse model for autosomal dominant hypocalcaemia type 1 (ADH1)

Immunomodulation by vitamin D is associated with regulation of microRNAs

Ionised calcium from blood gas measurements, often overlooked

Studies of an Autosomal Dominant Hypocalcemia type-1 (ADH1) associated calcium-sensing receptor (CaSR) mutation, Arg680Gly, provides insights into biased signalling

Emergency management of hypercalcemia (an audit of SfE guidance in Oxford)

The impact of primary hyperparathyroidism and its treatment on bone mineral density, bone mineral parameters, insulin resistance, body composition and quality of life – A prospective pilot study from India

Impact of hepatitis B-related chronic liver disease and its therapy on bone health

An audit of the management of patients with hypoparathyroidism

Continuous synthetic PTH_1-34 replacement therapy in the treatment of autosomal dominant hypoparathyroidism type 1

Importance of bone mineral density care in transitional endocrine service

Surgical management of primary hyperparathyroidism in East Sussex Healthcare NHS Trust (retrospective audit of patients had parathyroidectomy over 2 years in East Sussex NHS Trust)

Preoperative localisation for parathyroid surgery in primary hyperparathyroidism: a study to evaluate the clinical utility of different imaging modalities

An audit of vertebral fracture assessment (VFA) selection criteria: Implications for the service and impact on clinical decision making

Initial experience of a newly established intra-operative PTH service

Procollagen N-terminal propeptide in children

Primary hyperparathyroidism and concomitant vitamin D deficiency: Study of diagnosis and management outcomes

Would a 10% fracture risk threshold for direct access to dual energy densitometry (DXA) exclude patients with low bone mineral density?

FGF23, iron and vitamin D metabolism in chronic kidney disease

BiosciAbstracts